Keeping Track: Chugai Delivers Two Breakthroughs For Roche; FDA Continues To Wrestle With Opioid Regulation

The latest drug development news and highlights from our FDA Performance Tracker.

For FDA, it was a week of a lot of regulating but not much approving. Here's your news in brief:

Roche reached 14 breakthrough therapy designations (BTDs) from FDA, the most for any company, after receiving new designations for...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America